Dr. Heath D. Skinner
Overview
Heath D. Skinner, MD, PhD, is chair and medical director of the Department of Radiation Oncology and professor at UPMC Hillman Cancer Center, specializing in the study and treatment of head and neck and lung cancer. Dr. Skinner's research is designed to generate insights that led to the rational design of clinical trials using agents that are currently under investigation to minimize the time from bench to bedside. Dr. Skinner is board-certified in radiation oncology. He completed a combined MD/PhD program at West Virginia University. Upon completion of medical school, he began a combined internship and residency in radiation oncology at the University of Texas MD Anderson Cancer Center (MDACC). Over the course of his career, Dr. Skinner has received eight peer-reviewed grants, including a two current R01s funding his research. He has published over 85 peer-reviewed articles , has written 6 book chapters and 9 invited reviews and presented over 50 abstracts at national meetings. Dr. Skinner has also been invited to present his work at multiple domestic and international symposia. In addition to his research, Dr. Skinner is dedicated to providing excellent and compassionate patient care. This dedication is borne out in patient experience measures, with his scores being almost uniformly in the 99th percentile for all categories asked. Moreover, his patients have rated him in the top 1 percent nationally on Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) measures related to their experience with him in his clinic.
Dr. Skinner is rated as an Experienced provider by MediFind in the treatment of Olfactory Neuroblastoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Anaplastic Thyroid Cancer, Lung Cancer, and Gastrostomy.
His clinical research consists of co-authoring 159 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Olfactory Neuroblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
5230 Centre Avenue, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
West Virginia University Medical Corporation
David Clump is a Radiation Oncologist in Morgantown, West Virginia. Dr. Clump is rated as a Distinguished provider by MediFind in the treatment of Olfactory Neuroblastoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, and Oral Squamous Cell Carcinoma. Dr. Clump is currently accepting new patients.
Mary Hillman Jennings Radiation Oncology Center At UPMC Shadyside
Christopher Wilke, MD, specializes in radiation oncology and is board-certified in radiation oncology by the American Board of Radiology. He practices at Mary Hillman Jennings Radiation Oncology Center and is affiliated with UPMC St Margaret, UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Passavant, UPMC East, UPMC Presbyterian, UPMC Shadyside, and UPMC Mercy. Dr. Wilke completed his fellowship at University of Texas MD Anderson Cancer Center and residency and medical education at University of Minnesota School of Medicine. Dr. Wilke is rated as an Advanced provider by MediFind in the treatment of Olfactory Neuroblastoma. His top areas of expertise are Optic Glioma, Throat Cancer, Laryngeal Cancer, and Olfactory Neuroblastoma.
Mary Hillman Jennings Radiation Oncology Center
Yvonne Mowery, MD, PhD, specializes in radiation oncology and is board-certified by the American Board of Radiology. She practices at Mary Hillman Jennings Radiation Oncology Center and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Mercy, UPMC Shadyside, and UPMC Presbyterian. Dr. Mowery completed her residency at Duke University Medical Center and medical education at Duke University School of Medicine. Dr. Mowery is rated as an Advanced provider by MediFind in the treatment of Olfactory Neuroblastoma. Her top areas of expertise are Throat Cancer, Laryngeal Cancer, Adult Soft Tissue Sarcoma, and Head and Neck Squamous Cell Carcinoma (HNSCC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Esophageal CancerDr. Skinner isDistinguished. Learn about Esophageal Cancer.
- Advanced
- Anaplastic Thyroid CancerDr. Skinner isAdvanced. Learn about Anaplastic Thyroid Cancer.
- Human Papillomavirus InfectionDr. Skinner isAdvanced. Learn about Human Papillomavirus Infection.
- Laryngeal CancerDr. Skinner isAdvanced. Learn about Laryngeal Cancer.
- Lung CancerDr. Skinner isAdvanced. Learn about Lung Cancer.
- Throat CancerDr. Skinner isAdvanced. Learn about Throat Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Skinner isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- ALK-Positive Non-Small Cell Lung CancerDr. Skinner isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Skinner isExperienced. Learn about EGFR Positive Lung Cancer.
- Gastroesophageal Junction CancerDr. Skinner isExperienced. Learn about Gastroesophageal Junction Cancer.
- GastrostomyDr. Skinner isExperienced. Learn about Gastrostomy.
- Large-Cell Lung CarcinomaDr. Skinner isExperienced. Learn about Large-Cell Lung Carcinoma.